Research Projects
People in the lab
Publications
Lab Alumnae
Scrapbook
Contact Information
Return to Main Page

Recent Publications

Erdman, S.E., V.P. Rao, T. Poutahidis, A.B. Rogers, C.L. Taylor, E.A. Jackson, Z. Ge, C.W. Lee, D.B. Schauer, G.N. Wogan, S.R. Tannenbaum and J.G. Fox. Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected Rag2 -deficient mice Proc. Nat. Acad. Sci. USA 106: 1027-1032, 2009.

Kim, M.Y., X. Zhou, K. Taghizadeh, P.C. Dedon and G. N. Wogan. AlkB mitigates mutagenesis of the pSP189 supF shuttle vector by etheno adducts derived from 2-chloroacetylaldehyde Chemical Res. Toxicol. 20: 1075-1083, 2007.

Kim, M.Y., N. Tretyakova and G. N. Wogan. Mutagenesis of the supF gene by stereoisomers of 1,2,3,4-diepoxybutane Chemical Res. Toxicol. 20: 790-797, 2007.

Kiziltepe T., T. Hideshima, K. Ishitsuka, E.M. Ocio, N.Raje, L. Catley, C.-Q. Li, L.J. Trudel, H.Yasui, S. Vallet, J.L. Kutok, D. Chauhan, C.S. Mitsiades, J.E. Saavedra, G.N. Wogan, L.K Keefer, P.J. Shami, and K.C. Anderson.. JS-K, a GST-activated nitric oxide generator, induces DNA double strand breaks, activates DNA damage response pathways and induces apoptosis in human multiple myeloma cells. Blood 110: 709-718, 2007.

Zayas, B., S. W. Stillwell, J.S. Wishnok, L. J. Trudel, P. Skipper, M.C. Yu, S. R. Tannenbaum and G.N. Wogan. Detection and quantification of 4-ABP adducts in DNA from bladder cancer patients. Carcinogenesis 28: 342-349, 2007

Wogan, G.N. Commentary: Does perinatal antiretroviral therapy create an iatrogenic cancer risk? Env. Mol. Mutagen. 48: 210-214, 2007.

Kim, M.Y and G.N. Wogan. Mutagenesis of the supF Gene of pSP189 Replicating in AD293 Cells Co-cultivated with Activated Macrophages: Roles of Nitric Oxide and Reactive Oxygen Species. Chemical Res. Toxicol., 19: 1483-1491, 2006

Jang, H.G,, M. Park, J.S. Wishnok, S.R. Tannenbaum and G.N. Wogan. Hydroxyl-specific fluorescence labeling of ABP-deoxyguanosine, PhIP-deoxyguanosine and AFB1-formamidopyrimidine with BODIPY-FL. Analytical Biochem. 359: 151-160, 2006

Skipper, P.L., L.J. Trudel, T.W. Kensler, J.D. Groopman, P. Egner, R.G. Liberman, G.N. Wogan and S.R Tannenbaum. DNA adduct formation by 2,6-dimethyl-, 3,5-dimethyl- and 3-ethylaniline in vivo in mice. Chem. Res. Toxicol. 19: 1086-1090, 2006

Li, C.-Q, B. Pang, T. Kiziltepe, L.J. Trudel, B.P. Engelward, P.C. Dedon, P.C., and G.N. Wogan. Threshold effects of nitric oxide-induced responses in wild-type and p53-null human lymphoblastoid cells. Chem. Res. Toxicol. 19: 399-406, 2006

Zipes, D.P., N.J. Zvaifler, R.J. Glassock, S. Gilman, A. Munoz, V. Gogolak, L. Gordis, L., P.C. Dedon, F.P Guengerich, S.I. Wasserman, J.L. Witztum, J.L., and G. N. Wogan. Rosuvastatin: An Independent Analysis of Risks and Benefits. MedGenMed. 2006, 8:73. Available at : http://medgenmed.medscape.com/viewarticle/533930. Accessed June 14, 2006.

Schulte-Hermann, R., G.N. Wogan, C. Berry, N.A. Brown, A. Czeizel, E. Giavinni, L.B. Holmes, R. Kroes, H. Nau, D. Neubert, F. Oesch, T. Ott, O. Pelkonen, E. Robert-Gnansia, and F.M. Sullivan. Analysis of reproductive toxicity and classification of glufosinate ammonium. Reg. Tox. Pharm. 44: S1-S76, 2006.

Li, C.-Q., T.L. Wright, M. Dong, Y.E.M. Dommels, P.C. Dedon, S.R. Tannenbaum and G. N. Wogan. Biological role of glutathione in nitric-oxide induced toxicity in cell culture and animal models. Free Rad. Biol. Med. 39: 1489-1498, 2005.

Kim, M.Y., Dong, M., Dedon, P.C. and G. N. Wogan. Effects of peroxynitrite dose and dose-rate on DNA damage and mutation in the supF shuttle vector. Chem. Res. Toxicol. 18: 76-86, 2005.

Li, C.-Q. and G.N.Wogan. Nitric oxide modulation of apoptosis. Cancer Lett. 226: 1-15, 2005.

Li, C.-Q., A.I. Robles, C.L. Hanigan, L.J. Hofseth, L.J. Trudel, C.C. Harris, and G.N. Wogan. Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53. Cancer Res. 64: 3022-3029, 2004.

Liu, Z., Hergenhahn M., Schmeiser, H, Wogan, G.N., Hong, A., and Hollstein, M. Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene. Proc. Nat. Acad. Sci. USA, 101: 2963-2968, 2004.

Wogan G.N., S.S. Hecht., J.S. Felton, A.H. Conney, and L.A. Loeb. Environmental and chemical carcinogenesis. Semin. Cancer Biol. Dec;14(6): 473-86, 2004.

Stoner, G.D., M.A. Morse and G.N. Wogan. Foods and food components in the prevention of cancer. In Bioprocesses and Biotechnology for Functional Foods and Nutraceuticals. J.-R Nesser and J.B. German, eds., Marcel Dekker, New York, 2004. pp 331-375.

Wang, C., Trudel, L.J., Wogan, G.N. and Deen, W.M. Thresholds of nitric oxide-mediated toxicity in human lymphoblastoid cells. Chem. Res. Toxicol. 16: 1004-1013, 2003.

Pamir, B. and Wogan G.N. CO2 modulation of peroxynitrite-induced mutagenesis of the supF gene in pSP189. Chem. Res. Toxicol. 16: 487-492, 2003.

Hofseth, L.J., Hussain, S.P., Wogan, G.N. and Harris, C.C. Nitric oxide in cancer and chemoprevention. Free Rad. Biol. Med. 34: 955-968, 2003.

Wright, T.L., Li, C.-Q., Trudel, L.J., Wogan, G.N. and Tannenbaum, S.R. Determination of nitric-oxide-induced effects on tissue levels of glutathione and mitochondrial membrane potential. Methods in Enzymol. 359: 319-328, 2003.

Li , C.-Q., Trudel, L.J. and Wogan, G.N. Nitric oxide-induced genotoxicity, mitochondrial damage and apoptosis in human lymphoblastoid cells expressing wild-type and mutant p53. Proc. Nat. Acad. Sci. 99: 10364-10369, 2002.

Li, C.-Q., Trudel, L.J. and Wogan, G.N. Genotoxicity, mitochondrial damage and apoptosis in human lymphoblastoid cells exposed to peroxynitrite generated from SIN-1. Chem. Res. Toxicol. 15: 527-535, 2002.

Zhuang, J.C., Lin, D., Lin, C., Jethwaney, D. and Wogan, G.N. Genotoxicity associated with NO production in macrophages and co-cultured target cells. Free Rad. Biol. Med. 33: 94-102, 2002.

Hussain, S.P., Raja, K., Armstad, P.A., Sawyer, M., Trudel, L.J., Wogan, G.N., Hofseth, L.J., Shields, P.G., Billiar, T.R., Trautwein, C., Hohler, T., Galle, P.R., Phillips, D.H., Markin, R., Marrogi, A.J. and Harris, C.C. Increased p53 mutation load in nontumorous human liver of Wilson disease and hemochromatosis: Oxyradical overload diseases. Proc. Nat. Acad. Sci. USA. 97: 12770-12775, 2000.

Tretyakova, N.Y., Burney, S., Pamir, B., Wishnok, J.S. , Dedon, P.C., Wogan, G.N. and Tannenbaum, S.R. Peroxynitrite-induced DNA damage: Correlation with the mutational spectrum. Mutation Res. 447: 287-303, 2000.

Zhuang, J.C., Wright, T., deRojas-Walker, T., Tannenbaum, S.R. and Wogan, G.N. Nitric oxide-induced mutations in the HPRT gene of human lymphoblastoid TK6 cells and in Salmonella typhimurium. Environ. Mol. Mutagen. 35: 39-47, 2000.

Moshinsky, D.L. and Wogan, G.N. UV-induced mutagenesis of human p53: Analysis using a double selection method. Environ. Mol. Mutagen. 35: 31-38, 2000.

Wogan, G.N. Impacts of chemicals on liver cancer risk. Sem. Cancer Biol. 10: 201-210, 2000.

Fu, P.P., L.S. Von Tungeln, G.J. Hammons, G. McMahon, G.N. Wogan, T.J. Flammang and F.F. Kadlubar. Metabolic activation capacity of neonatal mice in relation to the neonatal mouse tumorigenicity bioassay. Drug Met. Rev. 32: 241-266, 2000.

top

Copyright © 2003 Gerald N. Wogan, Ph.D. All Rights Reserved.
Site design: Academic Web Pages